{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:41:07Z","timestamp":1788381667389,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG070447"],"award-info":[{"award-number":["AG070447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG071985"],"award-info":[{"award-number":["AG071985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS121826"],"award-info":[{"award-number":["NS121826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bmc.2024.117613","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T08:27:18Z","timestamp":1706430438000},"page":"117613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and \u03b1-synuclein fibrils"],"prefix":"10.1016","volume":"100","author":[{"given":"Ahmed A.","family":"Elbatrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo A.","family":"Ademoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Alnakhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arati","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashique","family":"Zami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Ostafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-9360","authenticated-orcid":false,"given":"Jessica S.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117613_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","article-title":"2010 Alzheimer\u2019s disease facts and figures","volume":"6","author":"Association","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bmc.2024.117613_b0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and Alzheimer disease: the egg and the chicken scenario","volume":"21","author":"Saez-Atienzar","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2024.117613_b0015","first-page":"216","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: A review","author":"Srivastava","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117613_b0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease \u2014 repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bmc.2024.117613_b0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.parkreldis.2012.11.009","article-title":"Pain in parkinson disease: A review of the literature","volume":"19","author":"Fil","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.bmc.2024.117613_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease - Epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bmc.2024.117613_b0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.bmc.2024.117613_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117613_b0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: Time, space and \u201cwingmen\u201d","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmc.2024.117613_b0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bmc.2024.117613_b0055","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(22)02480-1","article-title":"Lecanemab for Alzheimer\u2019s disease: tempering hype and hope","volume":"400","author":"Lancet","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117613_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2024.117613_b0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2024.117613_b0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.bmc.2024.117613_b0075","article-title":"Lecanemab trial finds slight slowing of cognitive decline, but clinical benefits are uncertain","volume":"379","author":"Mahase","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.bmc.2024.117613_b0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy - Moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bmc.2024.117613_b0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.bmc.2024.117613_b0090","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acssensors.1c00338","article-title":"\u201cturn-On\u201d quinoline-based fluorescent probe for selective imaging of tau aggregates in alzheimer\u2019s disease: rational design, synthesis, and molecular docking","volume":"6","author":"Elbatrawy","year":"2021","journal-title":"ACS Sens."},{"key":"10.1016\/j.bmc.2024.117613_b0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in alzheimer\u2019s disease: Mechanisms and therapeutic strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bmc.2024.117613_b0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41594-018-0057-1","article-title":"Mapping interactions with the chaperone network reveals factors that protect against tau aggregation","volume":"25","author":"Mok","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmc.2024.117613_b0105","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1007\/s12035-023-03387-8","article-title":"The role of tau proteoforms in health and disease","volume":"60","author":"Waheed","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.117613_b0110","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/bi036094h","article-title":"Ligand-dependent inhibition and reversal of tau filament formation","volume":"43","author":"Chirita","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117613_b0115","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1021\/bi050387o","article-title":"Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: Implications for the treatment of tauopathic neurodegenerative diseases","volume":"44","author":"Necula","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117613_b0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117613_b0125","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/cpt.1374","article-title":"Progress of pharmacological approaches in parkinson\u2019s disease","volume":"105","author":"Zeuner","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bmc.2024.117613_b0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u03b1-Synuclein misfolding and Parkinson\u2019s disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.bmc.2024.117613_b0135","first-page":"709","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies","author":"Henderson","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bmc.2024.117613_b0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.bmc.2024.117613_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2024.117613_b0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bmc.2024.117613_b0155","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bbagen.2015.05.021","article-title":"Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to \u03b1-synuclein aggregates","volume":"1850","author":"Deeg","year":"2015","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.bmc.2024.117613_b0160","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau interacts with the C-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117613_b0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Colom-Cadena","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bmc.2024.117613_b0170","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jmb.2018.04.020","article-title":"Synergistic amyloid switch triggered by early heterotypic oligomerization of intrinsically disordered \u03b1-synuclein and tau","volume":"430","author":"Bhasne","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117613_b0175","doi-asserted-by":"crossref","first-page":"e20192193","DOI":"10.1084\/jem.20192193","article-title":"\u03b1-Synuclein modulates tau spreading in mouse brains","volume":"218","author":"Bassil","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2024.117613_b0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bmc.2024.117613_b0185","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/ja3115696","article-title":"Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils","volume":"135","author":"Palhano","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2024.117613_b0190","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117613_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.febslet.2014.11.026","article-title":"The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios","volume":"589","author":"Wobst","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2024.117613_b0200","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3390\/ijms12095592","article-title":"Epigallocatechin-3-gallate (EGCG) for clinical trials: More Pitfalls than Promises?","volume":"12","author":"Mereles","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117613_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14189","article-title":"Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies","volume":"46","author":"Mehmood","year":"2022","journal-title":"J Food Biochem"},{"key":"10.1016\/j.bmc.2024.117613_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127514","article-title":"Structural hybridization as a facile approach to new drug candidates","volume":"30","author":"Sampath Kumar","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117613_b0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1385272823666191021124443","article-title":"Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases","volume":"18","author":"Gontijo","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.bmc.2024.117613_b0220","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2024.117613_b0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","article-title":"An overview of molecular hybrids in drug discovery","volume":"11","author":"B\u00e9rub\u00e9","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2024.117613_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133574","article-title":"Anti-fibrillization effects of sulfonamide derivatives on \u03b1-synuclein and hyperphosphorylated tau isoform 1N4R","volume":"1267","author":"Fortin","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117613_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131569","article-title":"In vitro characterization of urea derivatives to inhibit alpha-synuclein early-stage aggregation","volume":"1249","author":"Maity","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117613_b0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: History of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J Struct Biol"},{"key":"10.1016\/j.bmc.2024.117613_b0245","doi-asserted-by":"crossref","first-page":"20102","DOI":"10.1021\/acsomega.3c02668","article-title":"5-Nitro-1,2-benzothiazol-3-amine and N-Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate \u03b1-Synuclein and Tau Aggregation","volume":"8","author":"Ramirez","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2024.117613_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155193","article-title":"Rapid alpha-synuclein toxicity in a neural cell model and its rescue by a stearoyl-coa desaturase inhibitor","volume":"21","author":"Terry-Kantor","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117613_b0255","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"PNAS"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:25:26Z","timestamp":1760837126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624000270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"alternative-id":["S0968089624000270"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117613","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and \u03b1-synuclein fibrils","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117613"}}